Ciprofloxacin Hydrochloride Injection (盐酸环丙沙星注射液)盐酸环丙沙星注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

环丙沙星是一种在国家药监局注册认定的药品。该药品含有环丙沙星-de3858a3等成分。

该药品关联的活性成分包括:环丙沙星ciprofloxacin。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:包头康力药业集团股份有限公司Chinese legal name: 包头康力药业集团股份有限公司。

您可以探索含有相同成分的其他药品:环丙沙星-de3858a3成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

ciprofloxacin is a medicine registered with the national drug regulatory authority. It contains ciprofloxacin as active ingredient(s).

Active ingredients associated with this product: ciprofloxacinciprofloxacin.

Manufacturers recorded for this product: 包头康力药业集团股份有限公司Chinese legal name: 包头康力药业集团股份有限公司.

Explore other medicines containing the same ingredient: ciprofloxacin products.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 盐酸环丙沙星注射液Ciprofloxacin Hydrochloride Injection (盐酸环丙沙星注射液)
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 100ml:0.2g100 mL:0.2 g

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 包头康力药业集团股份有限公司Chinese legal name: 包头康力药业集团股份有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H15021471

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H15021471

Manufacturer

Chinese legal name: 包头康力药业集团股份有限公司

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H15021471

生产企业

包头康力药业集团股份有限公司

适应症

1.泌尿生殖系统感染,包括单纯性、复杂性尿路感染、细菌性前列腺炎、淋病奈瑟菌尿道炎或宫颈炎(包括产酶株所致者)。|2.呼吸道感染,包括敏感革兰阴性杆菌所致支气管感染急性发作及肺部感染。|3.胃肠道感染,由志贺菌属、沙门菌属、产肠毒素大肠杆菌、亲水气单胞菌、副溶血弧菌等所致。|4.伤寒。|5.骨和关节感染。|6.皮肤软组织感染。|7.败血症等全身感染。

用法用量

常用量,静脉滴注一次200mg,一日两次或一次400mg一日一次。

不良反应

常见不良反应为胃肠道反应,如恶心、呕吐、食欲减退、腹泻等,其次为中枢神经系统反应,表现为头晕、头痛等,此外偶见荨麻疹、瘙痒、肝酶升高及注射局部刺激症状。

禁忌

对本品及喹诺酮类药物过敏者、18岁以下患者、孕妇及哺乳期妇女禁用。

注意事项

1.肾功能损害者慎用或减量使用。|2.原有癫痫或其他中枢神经系统疾患者避免使用。|3.避免与氨茶碱、咖啡因等同时应用,如需同时应用时,应对上述二种药物血浓度进行监测以调整该二种药物的剂量。|4.本品静脉滴注宜缓慢,每0.2g/100ml滴注时间不少于1小时。

贮藏

密封,置阴凉处。

规格

100ml:0.2g

证据Evidence

  • 批准文号: 国药准字H15021471
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.